Gyno-Pevaryl

Gyno-Pevaryl is a vaginal formulation containing the antifungal agent econazole nitrate. The product is marketed in the European Union and is classified as an imidazole antifungal (ATC code D01AC02). Econazole nitrate works by inhibiting fungal ergosterol synthesis, which disrupts cell membrane integrity. Gyno-Pevaryl is intended for local treatment of fungal infections of female genital tract, vulvovaginal candidiasis. It is supplied without a specified strength and is designed for intravaginal use.

Gyno-Pevaryl is indicated for the treatment of fungal infections of the vagina caused by susceptible Candida species.

- Treatment of uncomplicated vulvovaginal candidiasis - Management of recurrent vulvovaginal candidiasis when other therapies have failed - Adjunct therapy for mixed bacterial‑fungal vaginal infections - Prophylactic application after antibiotic therapy to reduce risk of yeast overgrowth - Treatment of Candida infections in patients with diabetes mellitus when systemic therapy is not indicated - Use in patients who require a topical antifungal with a broad spectrum of activity

The safety profile of Gyno-Pevaryl reflects the typical local tolerability of imidazole antifungals applied intravaginally.

Common: - Mild vaginal irritation or burning - Itching or pruritus at the application site - Slight abnormal vaginal discharge - Temporary dysuria - Local dryness or peeling of vaginal mucosa - Mild abdominal cramps

Serious: - Severe allergic reaction (e.g., rash, swelling, difficulty breathing) - Persistent or worsening vaginal symptoms despite therapy - Signs of secondary bacterial infection (fever, foul odor) - Rare cases of hepatic enzyme elevation reported with extensive use - Stevens‑Johnson syndrome (very rare)

Before using Gyno-Pevaryl, certain precautions should be considered to ensure safe and effective therapy.

- Confirm diagnosis of Candida infection before initiating treatment - Avoid use if known hypersensitivity to econazole nitrate or other imidazoles - Do not use in the presence of active vaginal bleeding or ulceration - Limit treatment duration to the prescribed course; prolonged use may increase risk of resistance - Consult a healthcare professional if symptoms persist beyond 7 days - Use caution in pregnant or breastfeeding women; safety data are limited - Keep product out of reach of children

Gyno-Pevaryl may interact with other medications or substances applied to the vaginal area.

Avoid: - Concurrent use of other topical antifungal agents (e.g., clotrimazole, miconazole) without medical advice - Use with vaginal spermicides or douches that may alter mucosal absorption

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase systemic exposure - Hormonal contraceptives delivered vaginally, as irritation may affect absorption - Antibiotics that disrupt normal flora, potentially increasing yeast overgrowth after treatment